Mumbai, July 22 (IANS) India’s pharmaceutical sector dipped notably on Wednesday after US President Donald Trump outlined a phased tariff plan on imported generic medicines, fuelling concerns over the long‑term outlook for drugmakers that rely heavily on US sales.The Nifty Pharma index fell nearly 2 per cent in early trade, making it the worst‑performing sectoral index on the National Stock Exchange in early trade.The Nifty Pharma index fell 1.85 per cent to 25,610 against Nifty, down 169 …
Trending
- The Revolutionaries Review 2026: Nikkhil Advani’s Powerful Tribute To India’s Forgotten Freedom Fighters
- Chumbak Review: Neena Gupta’s Warm Netflix Sitcom Is 2026’s Most Heartfelt Comedy Comfort Watch
- Mandaadi Movie Review: Soori’s Sailboat Saga Sails to a Solid Win in 2026
- Video Movie Review (2026): Kannada Horror Delivers Bone-Chilling Thrills That Will Keep You Hooked
- Epic – The First Semester Review 2026: A Heartfelt Ode to Young Love That Wins Big
- America America 2 Movie Review (2026): A Heartfelt Millennial Love Story Worth Watching
- Sardar 2 Movie Review 2026: Karthi’s Explosive Double Act Delivers a Thrilling Spy Saga
- Ghamasaan Movie Review 2026: A Gripping Arshad Warsi-Pratik Gandhi Showdown
